Adult Dosing
Allergic rhinitis
- Start: 64 mcg (1 spray/nostril) Daily
- Max: 256 mcg (4 spray/nostril) Daily
Note: Discontinue therapy after 3wks if no improvement
Pediatric Dosing
Allergic rhinitis
- 6-12 yrs
- Start: 64 mcg (1 spray/nostril) Daily
- Max: 128 mcg (2 spray/nostril) Daily
- >12yrs
- Start: 64 mcg (1 spray/nostril) Daily
- Max: 256 mcg (4 spray/nostril) Daily
Note: Discontinue therapy after 3wks if no improvement
[Outline]
See Supplemental Patient Information
- Bone mineral density (BMD) have decreased on prolong use of inhaled corticosteroids
- Candida albicans infection of the mouth and pharynx have occurred, periodically monitor patients for signs of adverse effects
- Corticosteroids cause development of glaucoma and/or cataracts. Monitor patients with history of increased IOP, glaucoma, and/or cataracts for changes in vision
- Reduction in growth velocity may occur in pediatric patients; monitor periodically
- Increased risk of immunosuppression and infections; avoid exposure of patients who have not suffered from chickenpox/measles or have been properly immunized. Start prophylaxis with varicella zoster immune globulin (VZIG) if exposed to chickenpox and with pooled immunoglobulin (IG) if exposed to measles
- Worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infection, or ocular herpes simplex, serious or life threatening course of chickenpox or measles in susceptible patients may occur
- Adrenal insufficiency and hypercorticism may occur at higher than recommended dosages or even at recommended dosages in susceptible individuals. Withdraw gradually to discontinue
- Epistaxis, nasal septal perforation, nasopharyngeal candida infections may occur. Periodically examine patients for evidence of candida infections and adverse effects on the nasal mucosa. Discontinue use in the event of localized nasopharyngeal infections
- Avoid spraying directly in to the nasal septum
- Has an inhibitory effect on wound healing, prohibit use in patients with unhealed nasal septal ulcer, nasal surgery or trauma
Cautions: Use cautiously in
- Active or quiescent tuberculosis infections of the respiratory tract
- Untreated local or systemic fungal or bacterial infections
- Systemic viral or parasitic infections
- Tuberculosis infections
- Ocular herpes simplex infections
- Recurrent epistaxis
- Measles or varicella exposure
- Glaucoma
- Cataracts
- Increased intra ocular pressure
- Adrenal insufficiency
- Adrenal suppression
- Hypercorticism
Supplemental Patient Information
- Advise patients to avoid spraying in eyes or mouth
- Advise patients to read patient instructions before they start using their nasal spray
Pregnancy Category:B
Breastfeeding: Less amounts of inhaled budesonide are excreted into breastmilk and negligible amount is exposed to infant. Inhaled corticosteroids are considered acceptable to use during breastfeeding. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 25 February 2011). According to manufacturer's data a decision is essential for discontinuing nursing or discontinuing the drug taking into account the importance of the drug to the mother.
Pricing data from www.DrugStore.com in U.S.A.
- Rhinocort Aqua 32 MCG/ACT SUSP [Bottle] (ASTRAZENECA LP)
8.6 act = $115.99
25.8 act = $329.99
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.